{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:18:30Z","timestamp":1792055910601,"version":"4.4.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.semcancer.2006.03.009","type":"journal-article","created":{"date-parts":[[2006,4,7]],"date-time":"2006-04-07T11:23:26Z","timestamp":1144409006000},"page":"225-234","source":"Crossref","is-referenced-by-count":91,"title":["Regulation of the p53-MDM2 pathway by 14-3-3 \u03c3 and other proteins"],"prefix":"10.1016","volume":"16","author":[{"given":"Mong-Hong","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2006.03.009_bib1","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1146\/annurev.pharmtox.40.1.617","article-title":"14-3-3 proteins: structure, function, and regulation","volume":"40","author":"Fu","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0092-8674(00)80487-0","article-title":"The structural basis for 14-3-3:phosphopeptide binding specificity","volume":"91","author":"Yaffe","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-0004(00)88971-9","article-title":"14-3-3 proteins on the MAP","volume":"20","author":"Aitken","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.semcancer.2006.03.009_bib4","doi-asserted-by":"crossref","first-page":"18891","DOI":"10.1074\/jbc.M500982200","article-title":"A structural basis for 14-3-3sigma functional specificity","volume":"280","author":"Wilker","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.cr.7290290","article-title":"The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization","volume":"15","author":"Benzinger","year":"2005","journal-title":"Cell Res"},{"key":"10.1016\/j.semcancer.2006.03.009_bib6","first-page":"507","article-title":"Complementary DNA cloning of a novel epithelial cell marker protein, Hme1, that may be down-regulated in neoplastic mammary cells","volume":"3","author":"Prasad","year":"1992","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.semcancer.2006.03.009_bib7","doi-asserted-by":"crossref","first-page":"23106","DOI":"10.1074\/jbc.M905616199","article-title":"Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression","volume":"275","author":"Laronga","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib8","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/44188","article-title":"14-3-3sigma is required to prevent mitotic catastrophe after DNA damage","volume":"401","author":"Chan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2006.03.009_bib9","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1128\/MCB.23.20.7096-7107.2003","article-title":"14-3-3sigma positively regulates p53 and suppresses tumor growth","volume":"23","author":"Yang","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1083\/jcb.149.5.1117","article-title":"Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes","volume":"149","author":"Dellambra","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib11","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1073\/pnas.100566997","article-title":"High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer","volume":"97","author":"Ferguson","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/modpathol.3800240","article-title":"Downregulation of 14-3-3sigma in ovary, prostate and endometrial carcinomas is associated with CpG island methylation","volume":"18","author":"Mhawech","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib13","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1158\/1078-0432.CCR-03-0510","article-title":"Decreased expression of 14-3-3 sigma is associated with advanced disease in human epithelial ovarian cancer: its correlation with aberrant DNA methylation","volume":"10","author":"Akahira","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcancer.2006.03.009_bib14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjc.6602004","article-title":"Frequent downregulation of 14-3-3 sigma protein and hypermethylation of 14-3-3 sigma gene in salivary gland adenoid cystic carcinoma","volume":"91","author":"Uchida","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semcancer.2006.03.009_bib15","first-page":"4353","article-title":"Inactivation of the 14-3-3 sigma gene is associated with 5\u2032 CpG island hypermethylation in human cancers","volume":"60","author":"Suzuki","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2006.03.009_bib16","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.1038\/sj.onc.1203898","article-title":"Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma","volume":"19","author":"Iwata","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2006.03.009_bib17","doi-asserted-by":"crossref","first-page":"9034","DOI":"10.1038\/sj.onc.1208004","article-title":"Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression","volume":"23","author":"Lodygin","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2006.03.009_bib18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bbrc.2004.05.056","article-title":"14-3-3sigma is down-regulated in human prostate cancer","volume":"319","author":"Urano","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.semcancer.2006.03.009_bib19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/dna.2005.24.264","article-title":"Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions","volume":"24","author":"Henrique","year":"2005","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib20","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.1038\/sj.onc.1206854","article-title":"Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma","volume":"22","author":"Lodygin","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2006.03.009_bib21","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/sj.onc.1205303","article-title":"Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers","volume":"21","author":"Osada","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2006.03.009_bib22","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrc1230","article-title":"The 14-3-3 cancer connection","volume":"3","author":"Hermeking","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2006.03.009_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/sj.cr.7290292","article-title":"The role of epigenetic inactivation of 14-3-3sigma in human cancer","volume":"15","author":"Lodygin","year":"2005","journal-title":"Cell Res"},{"issue":"6","key":"10.1016\/j.semcancer.2006.03.009_bib24","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1158\/0008-5472.CAN-05-3620","article-title":"DNA damage-induced protein 14-3-3 sigma inhibits PKB\/Akt activation and suppresses Akt-activated cancer","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcancer.2006.03.009_bib25","doi-asserted-by":"crossref","unstructured":"Yang H, Zhang Y, Wen YY, Zhao R, Fournier K, Yang HY, et al. Negative cell cycle regulator 14-3-3 sigma stabilizes p27 Kip1 by inhibiting the activity of PKB\/Akt. Oncogene 2006 [Epub ahead of print].","DOI":"10.1038\/sj.onc.1209481"},{"key":"10.1016\/j.semcancer.2006.03.009_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1158\/1535-7163.MCT-05-0395","article-title":"14-3-3{sigma}, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma","volume":"5","author":"Yang","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semcancer.2006.03.009_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","article-title":"14-3-3 sigma is a p53-regulated inhibitor of G2\/M progression","volume":"1","author":"Hermeking","year":"1997","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2006.03.009_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng837","article-title":"BRCA1 regulates the G2\/M checkpoint by activating Chk1 kinase upon DNA damage","volume":"30","author":"Yarden","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2006.03.009_bib30","doi-asserted-by":"crossref","first-page":"25647","DOI":"10.1074\/jbc.C100265200","article-title":"BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells","volume":"276","author":"Aprelikova","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/ng0894-472","article-title":"A physical map and candidate genes in the BRCA1 region on chromosome 17q12\u201321","volume":"7","author":"Albertsen","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2006.03.009_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2006.03.009_bib33","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1073\/pnas.95.5.2302","article-title":"BRCA1 regulates p53-dependent gene expression","volume":"95","author":"Ouchi","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib34","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1038\/sj.onc.1204777","article-title":"14-3-3 proteins; bringing new definitions to scaffolding","volume":"20","author":"Tzivion","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2006.03.009_bib35","first-page":"993","article-title":"MDM2, an introduction","volume":"1","author":"Iwakuma","year":"2003","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.semcancer.2006.03.009_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-8674(02)01255-2","article-title":"Parc: a cytoplasmic anchor for p53","volume":"112","author":"Nikolaev","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib37","doi-asserted-by":"crossref","first-page":"48836","DOI":"10.1074\/jbc.M407601200","article-title":"Hsp90 chaperones wild-type p53 tumor suppressor protein","volume":"279","author":"Walerych","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0969-2126(02)00776-1","article-title":"Crystal structure of the FHA domain of the Chfr mitotic checkpoint protein and its complex with tungstate","volume":"10","author":"Stavridi","year":"2002","journal-title":"Structure (Camb)"},{"key":"10.1016\/j.semcancer.2006.03.009_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/542","article-title":"ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins","volume":"19","author":"Waterman","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.semcancer.2006.03.009_bib40","doi-asserted-by":"crossref","first-page":"48013","DOI":"10.1074\/jbc.M310801200","article-title":"The transcriptional repressor hDaxx potentiates p53-dependent apoptosis","volume":"279","author":"Gostissa","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib41","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1093\/nar\/gkg741","article-title":"Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML","volume":"31","author":"Kim","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.semcancer.2006.03.009_bib42","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nature00826","article-title":"Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth","volume":"417","author":"Urano","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2006.03.009_bib43","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/sj.onc.1207414","article-title":"Nedd8 on cullin: building an expressway to protein destruction","volume":"23","author":"Pan","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2006.03.009_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cell.2004.06.016","article-title":"Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity","volume":"118","author":"Xirodimas","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib45","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0092-8674(03)00193-4","article-title":"Pirh2, a p53-induced ubiquitin\u2013protein ligase, promotes p53 degradation","volume":"112","author":"Leng","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib46","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nature02514","article-title":"The ubiquitin ligase COP1 is a critical negative regulator of p53","volume":"429","author":"Dornan","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2006.03.009_bib47","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1074\/jbc.M312712200","article-title":"Control of human PIRH2 protein stability: involvement of TIP60 and the proteosome","volume":"279","author":"Logan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib48","doi-asserted-by":"crossref","first-page":"19682","DOI":"10.1074\/jbc.M212681200","article-title":"Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity","volume":"278","author":"Bianchi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib49","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/embo-reports\/kve227","article-title":"Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms","volume":"2","author":"Stad","year":"2001","journal-title":"EMBO Rep"},{"key":"10.1016\/j.semcancer.2006.03.009_bib50","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1128\/MCB.25.21.9608-9620.2005","article-title":"DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation","volume":"25","author":"Okamoto","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib51","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1038\/sj.emboj.7600812","article-title":"ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage","volume":"24","author":"Chen","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2006.03.009_bib52","doi-asserted-by":"crossref","unstructured":"Lebron C, Chen L, Gilkes DM, Chen J. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. EMBO J 2006.","DOI":"10.1038\/sj.emboj.7601032"},{"key":"10.1016\/j.semcancer.2006.03.009_bib53","doi-asserted-by":"crossref","unstructured":"Jin Y, Dai MS, Lu SZ, Xu Y, Luo Z, Zhao Y, et al. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation. EMBO J 2006.","DOI":"10.1038\/sj.emboj.7601010"},{"key":"10.1016\/j.semcancer.2006.03.009_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1097-2765(00)00006-X","article-title":"14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation","volume":"6","author":"Datta","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/19328","article-title":"Direct control of the Forkhead transcription factor AFX by protein kinase B","volume":"398","author":"Kops","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2006.03.009_bib57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1101-973","article-title":"HER-2\/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation","volume":"3","author":"Zhou","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib58","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib59","doi-asserted-by":"crossref","first-page":"35510","DOI":"10.1074\/jbc.M404936200","article-title":"Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B\/Akt-dependent phosphorylation","volume":"279","author":"Feng","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcancer.2006.03.009_bib61","doi-asserted-by":"crossref","first-page":"15587","DOI":"10.1073\/pnas.95.26.15587","article-title":"The PTEN\/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase\/Akt pathway","volume":"95","author":"Wu","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib62","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/35096067","article-title":"PKB\/AKT: functional insights from genetic models","volume":"2","author":"Scheid","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(03)00021-7","article-title":"PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms","volume":"3","author":"Freeman","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib64","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1097-2765(01)00323-9","article-title":"Regulation of PTEN transcription by p53","volume":"8","author":"Stambolic","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccr.2005.01.009","article-title":"Lack of PTEN sequesters CHK1 and initiates genetic instability","volume":"7","author":"Puc","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib66","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib68","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2005.03.037","article-title":"ARF-BP1\/Mule is a critical mediator of the ARF tumor suppressor","volume":"121","author":"Chen","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib69","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2005.08.016","article-title":"The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation","volume":"123","author":"Adhikary","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib70","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S1097-2765(02)00520-8","article-title":"c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability","volume":"9","author":"Vafa","year":"2002","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib71","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1073\/pnas.96.7.3940","article-title":"Transient excess of MYC activity can elicit genomic instability and tumorigenesis","volume":"96","author":"Felsher","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib72","doi-asserted-by":"crossref","first-page":"7669","DOI":"10.1128\/MCB.24.17.7669-7680.2004","article-title":"Inhibition of HDM2 and activation of p53 by ribosomal protein L23","volume":"24","author":"Jin","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib73","doi-asserted-by":"crossref","first-page":"7654","DOI":"10.1128\/MCB.24.17.7654-7668.2004","article-title":"Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition","volume":"24","author":"Dai","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib74","doi-asserted-by":"crossref","first-page":"44475","DOI":"10.1074\/jbc.M403722200","article-title":"Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5","volume":"279","author":"Dai","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcancer.2006.03.009_bib75","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1128\/MCB.23.23.8902-8912.2003","article-title":"Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway","volume":"23","author":"Zhang","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib76","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1535-6108(03)00134-X","article-title":"Regulation of HDM2 activity by the ribosomal protein L11","volume":"3","author":"Lohrum","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib77","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/JB.183.7.2316-2321.2001","article-title":"Loss of ribosomal protein L11 blocks stress activation of the Bacillus subtilis transcription factor sigma(B)","volume":"183","author":"Zhang","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib78","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb1147","article-title":"PML regulates p53 stability by sequestering Mdm2 to the nucleolus","volume":"6","author":"Bernardi","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.semcancer.2006.03.009_bib79","doi-asserted-by":"crossref","first-page":"6068","DOI":"10.1093\/emboj\/cdg579","article-title":"Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses","volume":"22","author":"Rubbi","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2006.03.009_bib80","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1101\/gad.886901","article-title":"ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage","volume":"15","author":"Maya","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcancer.2006.03.009_bib81","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cell.2004.11.054","article-title":"The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM\/ATR","volume":"120","author":"Park","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib82","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1101\/gad.914401","article-title":"Cell cycle checkpoint signaling through the ATM and ATR kinases","volume":"15","author":"Abraham","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcancer.2006.03.009_bib83","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.1073\/pnas.96.26.14973","article-title":"Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage","volume":"96","author":"Khosravi","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/71600","article-title":"Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas","volume":"6","author":"Higashitsuji","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.semcancer.2006.03.009_bib85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccr.2005.06.006","article-title":"The oncoprotein gankyrin binds to MDM2\/HDM2, enhancing ubiquitylation and degradation of p53","volume":"8","author":"Higashitsuji","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib86","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1097-2765(04)00157-1","article-title":"A dynamic role of HAUSP in the p53-Mdm2 pathway","volume":"13","author":"Li","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib87","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/cc.3.6.924","article-title":"HAUSP is required for p53 destabilization","volume":"3","author":"Cummins","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2006.03.009_bib88","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molcel.2005.04.024","article-title":"Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2","volume":"18","author":"Meulmeester","year":"2005","journal-title":"Mol Cell"},{"issue":"18","key":"10.1016\/j.semcancer.2006.03.009_bib89","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/sj.emboj.7600791","article-title":"MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation","volume":"24","author":"Wang","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2006.03.009_bib90","doi-asserted-by":"crossref","first-page":"12165","DOI":"10.1073\/pnas.0402283101","article-title":"YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress","volume":"101","author":"Gronroos","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib91","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cell.2004.06.004","article-title":"Yin Yang 1 is a negative regulator of p53","volume":"117","author":"Sui","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib92","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/emboj\/20.6.1331","article-title":"p300\/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2","volume":"20","author":"Ito","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.semcancer.2006.03.009_bib93","doi-asserted-by":"crossref","first-page":"12547","DOI":"10.1073\/pnas.97.23.12547","article-title":"MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins","volume":"97","author":"Kobet","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib94","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","article-title":"hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase","volume":"107","author":"Vaziri","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib95","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S1097-2765(01)00349-5","article-title":"Involvement of PIAS1 in the sumoylation of tumor suppressor p53","volume":"8","author":"Kahyo","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.semcancer.2006.03.009_bib96","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1073\/pnas.052559499","article-title":"Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity","volume":"99","author":"Schmidt","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcancer.2006.03.009_bib97","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/342705a0","article-title":"Mutations in the p53 gene occur in diverse human tumour types","volume":"342","author":"Nigro","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2006.03.009_bib98","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1128\/MCB.20.20.7764-7772.2000","article-title":"Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability","volume":"20","author":"Dhar","year":"2000","journal-title":"Mol Cell Biol"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X06000290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X06000290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T22:04:00Z","timestamp":1555538640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X06000290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":98,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1044579X06000290"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2006.03.009","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}